Documents & Downloads

E-2101

Antispastic Agent

E-2101 is a competitive inhibitor of cytochrome P450 enzymes CYP2C19 and CYP2D6, exhibiting Ki values of 15 μM and 48 μM, respectively. This novel antispastic agent is metabolized into various monohydroxylated (M1, M2), dihydroxylated (M3), and N-dealkylated (M4) metabolites. E-2101 is primarily utilized in research focusing on the treatment of skeletal muscle spasms, providing insights into muscle relaxation pathways and potential therapeutic interventions for associated disorders.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	265667-22-9
Applications	Antispastic Agent
Formula	C₂₄H₂₈FN₃O
Molecular Weight	393.50
SMILES	O=C(NC)CC1=CC2=C(C=C1)C=CN2C3CCN(CCC4=CC=CC=C4F)CC3

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.